CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q123 Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Revenues: Clearing and transaction fees 1,200.2 1,118.3 1,085.5 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 1,337.3 Market data and information services 165.8 163.1 167.6 167.2 175.4 175.0 178.2 181.6 194.5 Other Revenue 75.6 78.8 84.7 87.6 103.6 107.6 109.1 111.4 110.5 Total revenues 1,441.6 1,360.2 1,337.8 1,439.3 1,487.9 1,532.5 1,584.4 1,525.3 1,642.3 Expenses: Compensation and benefits 204.5 205.7 205.5 212.9 206.0 204.7 218.8 220.8 206.7 Technology 51.3 53.3 55.6 58.5 59.4 64.1 66.6 65.7 65.7 Professional fees and outside services 38.3 37.8 32.2 36.1 33.1 34.7 31.0 33.9 28.5 Amortization of purchased intangibles 56.8 57.0 57.2 55.6 55.2 55.5 55.7 55.3 55.2 Depreciation and amortization 31.9 32.3 31.1 30.7 30.1 28.7 28.2 28.1 27.3 Licensing and other fee agreements 84.7 78.2 79.5 80.4 87.9 85.9 97.6 84.0 96.6 Other expense 60.4 57.3 56.5 101.9 56.6 58.3 62.3 90.4 54.3 Operating expenses 527.9 521.6 517.6 576.1 528.3 531.9 560.2 578.2 534.3 Operating Income 913.7 838.6 820.2 863.2 959.6 1,000.6 1,024.2 947.1 1,108.0 Operating Margin 63% 62% 61% 60% 64% 65% 65% 62% 67% Non-operating Income and Expense Investment income 1,357.7 1,568.2 1,272.5 1,076.9 1,071.3 1,044.5 1,026.8 936.5 892.7 Interest and other borrowing costs (39.9) (40.2) (39.6) (39.7) (39.9) (40.1) (40.2) (40.7) (41.7) Equity in net gains (losses) of unconsolidated subsidiaries 78.2 75.1 76.8 66.8 87.2 86.4 86.1 91.2 88.2 Other non-operating income (expense) (1,152.8) (1,425.3) (1,155.6) (961.2) (964.8) (936.9) (920.0) (837.5) (802.4) Non-operating income (expense) 243.2 177.8 154.1 142.8 153.8 153.9 152.7 149.5 136.8 Income before income taxes 1,156.9 1,016.4 974.3 1,006.0 1,113.4 1,154.5 1,176.9 1,096.6 1,244.8 Income taxes 273.1 238.8 224.1 191.4 258.2 271.3 264.1 222.0 288.6 Net income 883.8 777.6 750.2 814.6 855.2 883.2 912.8 874.6 956.2 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 883.8 777.6 750.2 814.6 855.2 883.2 912.8 874.6 956.2 Net Income Attributable to Common Shareholders of CME Group 872.7 767.8 740.8 804.3 844.4 872.1 901.3 863.7 944.2 Effective Tax Rate 23.6% 23.5% 23.0% 19.0% 23.2% 23.2% 22.4% 20.2% 23.2% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 2.43 2.14 2.06 2.24 2.35 2.43 2.51 2.40 2.63 Diluted EPS 2.43 2.14 2.06 2.24 2.35 2.42 2.50 2.40 2.62 Weighted average number of common stock shares: Basic Shares 358,933 358,940 359,020 359,197 359,258 359,330 359,400 359,568 359,613 Diluted Shares 359,313 359,429 359,619 359,693 359,833 359,869 359,989 360,050 360,227 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q123 Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Revenues: Clearing and transaction fees 1,200.2 1,118.3 1,085.5 1,184.5 1,208.9 1,249.9 1,297.1 1,232.3 1,337.3 Market data and information services 165.8 163.1 167.6 167.2 175.4 175.0 178.2 181.6 194.5 Other Revenue 75.6 78.8 84.7 87.6 103.6 106.6 109.2 111.3 110.5 Total revenues 1,441.6 1,360.2 1,337.8 1,439.3 1,487.9 1,531.5 1,584.5 1,525.2 1,642.3 Expenses: Compensation and benefits 192.8 194.4 193.5 204.4 196.1 201.7 207.5 218.9 207.8 Technology 51.3 53.3 55.6 58.5 59.4 64.1 66.6 65.7 65.7 Professional fees and outside services 38.3 37.8 32.2 36.1 33.1 34.7 31.0 33.9 25.2 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 31.9 31.8 31.1 29.8 29.3 28.7 28.2 28.0 27.3 Licensing and other fee agreements 84.7 78.2 79.5 80.4 87.9 85.9 97.6 84.0 96.6 Other expense 59.7 56.2 56.5 80.3 56.5 58.6 57.9 89.7 52.0 Operating expenses 458.7 451.7 448.4 489.5 462.3 473.7 488.8 520.2 474.6 Operating Income 982.9 908.5 889.4 949.8 1,025.6 1,057.8 1,095.7 1,005.0 1,167.7 Operating Margin 68% 67% 66% 66% 69% 69% 69% 66% 71% Non-operating Income and Expense Investment income 1,277.5 1,564.0 1,276.6 1,068.5 1,061.7 1,033.0 1,022.3 943.8 892.3 Interest and other borrowing costs (39.9) (40.2) (39.6) (39.7) (39.9) (40.1) (40.2) (40.7) (41.7) Equity in net gains (losses) of unconsolidated subsidiaries 91.5 88.6 90.4 85.1 100.7 98.8 99.7 104.8 110.4 Other non-operating income (expense) (1,160.6) (1,429.9) (1,157.1) (958.8) (964.8) (936.9) (920.0) (837.5) (802.4) Non-operating income (expense) 168.5 182.5 170.3 155.1 157.7 154.8 161.8 170.4 158.6 Income before income taxes 1,151.4 1,091.0 1,059.7 1,104.9 1,183.3 1,212.6 1,257.5 1,175.4 1,326.3 Income taxes 269.1 254.6 241.7 240.2 272.2 280.4 280.5 256.5 306.4 Net income 882.3 836.4 818.0 864.7 911.1 932.2 977.0 918.9 1,019.9 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 882.3 836.4 818.0 864.7 911.1 932.2 977.0 918.9 1,019.9 Net Income Attributable to Common Shareholders of CME Group 871.1 825.9 807.8 853.8 899.7 920.4 964.7 907.4 1,007.1 Effective Tax Rate 23.4% 23.3% 22.8% 21.7% 23.0% 23.1% 22.3% 21.8% 23.1% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 2.43 2.30 2.25 2.38 2.50 2.56 2.68 2.52 2.80 Diluted EPS 2.42 2.30 2.25 2.37 2.50 2.56 2.68 2.52 2.80 Weighted average number of common stock shares: Basic Shares 358,933 358,940 359,020 359,197 359,258 359,330 359,400 359,568 359,613 Diluted Shares 359,313 359,429 359,619 359,693 359,833 359,869 359,989 360,050 360,227 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --